- Home
- INO vs GRX Comparison
INO vs GRX Comparison
Compare INO & GRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INO | GRX |
|---|---|---|
| Founded | 1979 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 132.9M |
| IPO Year | 1999 | 2007 |
Fundamental Metrics
Financial Performance| Metric | INO | GRX |
|---|---|---|
| Price | $1.64 | $8.98 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.75 | N/A |
| AVG Volume (30 Days) | ★ 695.8K | 30.7K |
| Earning Date | 03-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.18 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $42,220,086.00 | N/A |
| Revenue This Year | $24,407.60 | N/A |
| Revenue Next Year | $331.40 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.37 | N/A |
| 52 Week Low | $1.30 | $8.93 |
| 52 Week High | $2.86 | $10.08 |
Technical Indicators
Market Signals| Indicator | INO | GRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 27.82 |
| Support Level | $1.48 | N/A |
| Resistance Level | $1.78 | $9.68 |
| Average True Range (ATR) | 0.09 | 0.15 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 53.70 | 0.00 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About GRX The Gabelli Healthcare & Wellness Trust of Beneficial Interest
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.